174 related articles for article (PubMed ID: 18691116)
1. Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects.
van Blitterswijk WJ; Verheij M
Curr Pharm Des; 2008; 14(21):2061-74. PubMed ID: 18691116
[TBL] [Abstract][Full Text] [Related]
2. Anticancer mechanisms and clinical application of alkylphospholipids.
van Blitterswijk WJ; Verheij M
Biochim Biophys Acta; 2013 Mar; 1831(3):663-74. PubMed ID: 23137567
[TBL] [Abstract][Full Text] [Related]
3. Lipid rafts and metabolic energy differentially determine uptake of anti-cancer alkylphospholipids in lymphoma versus carcinoma cells.
Vink SR; van der Luit AH; Klarenbeek JB; Verheij M; van Blitterswijk WJ
Biochem Pharmacol; 2007 Nov; 74(10):1456-65. PubMed ID: 17803969
[TBL] [Abstract][Full Text] [Related]
4. A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells.
van der Luit AH; Vink SR; Klarenbeek JB; Perrissoud D; Solary E; Verheij M; van Blitterswijk WJ
Mol Cancer Ther; 2007 Aug; 6(8):2337-45. PubMed ID: 17699729
[TBL] [Abstract][Full Text] [Related]
5. Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents.
Zerp SF; Vink SR; Ruiter GA; Koolwijk P; Peters E; van der Luit AH; de Jong D; Budde M; Bartelink H; van Blitterswijk WJ; Verheij M
Anticancer Drugs; 2008 Jan; 19(1):65-75. PubMed ID: 18043131
[TBL] [Abstract][Full Text] [Related]
6. Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy.
Vink SR; van Blitterswijk WJ; Schellens JH; Verheij M
Cancer Treat Rev; 2007 Apr; 33(2):191-202. PubMed ID: 17287087
[TBL] [Abstract][Full Text] [Related]
7. Edelfosine and miltefosine effects on lipid raft properties: membrane biophysics in cell death by antitumor lipids.
Castro BM; Fedorov A; Hornillos V; Delgado J; Acuña AU; Mollinedo F; Prieto M
J Phys Chem B; 2013 Jul; 117(26):7929-40. PubMed ID: 23738749
[TBL] [Abstract][Full Text] [Related]
8. Antitumoral alkylphospholipids alter cell lipid metabolism.
Marco C; Ríos-Marco P; Jiménez-López JM; Segovia JL; Carrasco MP
Anticancer Agents Med Chem; 2014 May; 14(4):545-58. PubMed ID: 24628237
[TBL] [Abstract][Full Text] [Related]
9. Antitumor Lipids--Structure, Functions, and Medical Applications.
Kostadinova A; Topouzova-Hristova T; Momchilova A; Tzoneva R; Berger MR
Adv Protein Chem Struct Biol; 2015; 101():27-66. PubMed ID: 26572975
[TBL] [Abstract][Full Text] [Related]
10. Disruption of cellular cholesterol transport and homeostasis as a novel mechanism of action of membrane-targeted alkylphospholipid analogues.
Carrasco MP; Jiménez-López JM; Ríos-Marco P; Segovia JL; Marco C
Br J Pharmacol; 2010 May; 160(2):355-66. PubMed ID: 20423345
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids.
Jiménez-López JM; Ríos-Marco P; Marco C; Segovia JL; Carrasco MP
Lipids Health Dis; 2010 Mar; 9():33. PubMed ID: 20338039
[TBL] [Abstract][Full Text] [Related]
12. Caenorhabditis elegans as a platform to study the mechanism of action of synthetic antitumor lipids.
Sánchez-Blanco A; Rodríguez-Matellán AG; Reis-Sobreiro M; Sáenz-Narciso B; Cabello J; Mohler WA; Mollinedo F
Cell Cycle; 2014; 13(21):3375-89. PubMed ID: 25485582
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells.
Nieto-Miguel T; Fonteriz RI; Vay L; Gajate C; López-Hernández S; Mollinedo F
Cancer Res; 2007 Nov; 67(21):10368-78. PubMed ID: 17974980
[TBL] [Abstract][Full Text] [Related]
14. Combining anti-tumor alkyl-phospholipid analogs and radiotherapy: rationale and clinical outlook.
Verheij M; Moolenaar WH; Blitterswijk WJ
Anticancer Agents Med Chem; 2014 May; 14(4):618-28. PubMed ID: 24628238
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine.
Villa-Pulgarín JA; Gajate C; Botet J; Jimenez A; Justies N; Varela-M RE; Cuesta-Marbán Á; Müller I; Modolell M; Revuelta JL; Mollinedo F
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005805. PubMed ID: 28829771
[TBL] [Abstract][Full Text] [Related]
16. Impact of alkylphospholipids on the gene expression profile of HaCaT cells.
Semini G; Klein A; Danker K
Pharmacogenet Genomics; 2011 Jul; 21(7):375-87. PubMed ID: 21681147
[TBL] [Abstract][Full Text] [Related]
17. Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis.
Ruiter GA; Zerp SF; Bartelink H; van Blitterswijk WJ; Verheij M
Cancer Res; 1999 May; 59(10):2457-63. PubMed ID: 10344758
[TBL] [Abstract][Full Text] [Related]
18. Alkylphospholipids: An update on molecular mechanisms and clinical relevance.
Ríos-Marco P; Marco C; Gálvez X; Jiménez-López JM; Carrasco MP
Biochim Biophys Acta Biomembr; 2017 Sep; 1859(9 Pt B):1657-1667. PubMed ID: 28238819
[TBL] [Abstract][Full Text] [Related]
19. The alkylphospholipid edelfosine shows activity against Strongyloides venezuelensis and induces apoptosis-like cell death.
Legarda-Ceballos AL; Rojas-Caraballo J; López-Abán J; Ruano AL; Yepes E; Gajate C; Mollinedo F; Muro A
Acta Trop; 2016 Oct; 162():180-187. PubMed ID: 27394030
[TBL] [Abstract][Full Text] [Related]
20. Alkylphospholipids are Signal Transduction Modulators with Potential for Anticancer Therapy.
Kaleağasıoğlu F; Zaharieva MM; Konstantinov SM; Berger MR
Anticancer Agents Med Chem; 2019; 19(1):66-91. PubMed ID: 30318001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
